Irritable Bowel Syndrome (IBS)
CBD has shown promise in a number of gastrointestinal disorders, particularly autoimmune problems like Crohn’s. But a recent clinical trial of CBD may put a damper on hopes for treating ulcerative colitis.
Ohio researchers found Crohn’s Disease symptoms were 40-70% lower in patients using cannabis than non-users.
Three authors highlight that cannabis has shows better results than CBD alone for IBD.
The placebo effect happens when an expectation of benefit in a treatment creates the same response as an actual treatment. How does the power of thought influence the endocannabinoid system and our health?
A pioneer neurologist, Dr. Ethan Russo, examines recent scientific data on migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes that may respond to cannabinoid therapies.
Nausea is a feeling of sickness with an inclination to vomit. Nausea may be symptomatic of many conditions, including infection, food poisoning, motion sickness, overeating, blocked intestine, illness, concussion or brain injury, appendicitis, and migraines. They can also be a reaction to medications.
Digestive and bowel disorders include colitis, Crohn’s disease, inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS) and may cause pain, nausea, vomiting, bloating, constipation, diarrhea, or fatigue.
There are many ways to influence cannabinoid receptor signaling and enhance endocannabinoid tone—acupuncture, diet, osteopathic adjustments, etc.—as discussed in this peer-reviewed science article.